CareFirst moves for partial summary judgment in US antitrust case
( August 6, 2025, 20:12 GMT | Official Statement) -- MLex Summary: CareFirst moved for partial summary judgment in its antitrust litigation against Johnson & Johnson and Janssen Biotech. "The defendants Johnson & Johnson and Janssen Biotech, Inc. together engaged in exclusionary conduct by willful acquisition and maintenance of their monopoly power through acquisition of the Momenta biosimilar patents," Carefirst said in a court filing. "The defendants have failed to adduce sufficient evidence to establish any legitimate, procompetitive benefits for this exclusionary conduct." See plaintiffs' motion for partial summary judgment. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.